Form 4: Centene Director Theodore R. Samuels II Reports Acquisition of Restricted Stock Units
SEC Form 4
Director Theodore R. Samuels II reports acquisition of 3,579 restricted stock units and transactions involving common stock and options.
Summary
- Theodore R. Samuels II, a director of Centene Corp, filed a Form 4 detailing changes in beneficial ownership.
- On May 13, 2025, Samuels acquired 3,579 shares of restricted stock units at $0.
- These restricted stock units will vest in full on the earlier of May 13, 2026, or the date of Centene's next annual meeting of stockholders.
- Samuels also reported owning 18,031.979 shares of common stock directly and 23,000 shares indirectly through a family trust.
- Additionally, Samuels holds options to buy 10,000 shares of common stock at an exercise price of $80.57, exercisable from February 7, 2025, and expiring on February 7, 2032.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing transactions. The acquisition of restricted stock units can be seen as a slightly positive sign of confidence.
Positives
- The acquisition of restricted stock units aligns the director's interests with those of the shareholders.
- The vesting schedule encourages long-term commitment to the company's success.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting of restricted stock units in 2026 suggests a continued involvement of the director with the company.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates the director's continued investment in the company.
Comparison to Industry Standards
- Comparing the option exercise price of $80.57 to the current trading price of Centene (CNC) would provide context on the potential value of these options.
- Benchmarking the vesting schedule of the restricted stock units against similar grants at peer companies like UnitedHealth Group (UNH) or Anthem (ANTM) could reveal if the incentives are standard or unique.
Stakeholder Impact
- The director's transactions can influence investor sentiment and potentially impact the stock price.
- The vesting of restricted stock units aligns the director's interests with those of the shareholders, potentially leading to decisions that benefit the company's long-term value.
Next Steps
- Monitor future Form 4 filings by Samuels and other Centene insiders for further insights into their investment activities.
- Track the vesting of the restricted stock units in relation to the company's performance and stock price.
Key Dates
| Date | Description |
|---|---|
| 02/07/2025 | Date Common Stock Option (right to buy) becomes exercisable |
| 02/07/2032 | Expiration date of Common Stock Option (right to buy) |
| 05/13/2025 | Date of transaction: acquisition of restricted stock units |
| 05/13/2026 | Vesting date of restricted stock units (or earlier at next annual meeting) |
| 05/14/2025 | Date of signature |
Keywords
Form 4, Centene, Director, Samuels, Restricted Stock Units, Beneficial Ownership, Common Stock, Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.